Report of Scientific and Standardization Subcommittee on Neonatal Hemostasis

REFERENCES
1 Bleyer WA, Hakami N, Shepard TH. The development of hemostasis in the human fetus and newborn infant. J Pediatr 1971; 79: 838-853
2 Hathaway WE, Bonnar J. Perinatal Coagulation. Grune and Stratton, NewYork 1978
3 Corrigan Jr JJ. Normal hemostasis in fetus and newborn. Coagulation. In: Neonatal and Fetal Medicine Physiology and Pathophysiology. Polin RA, Fox WW. eds Grune and Stratton; New York: in press
4 Hathaway WE, Bonnar J. Hemostatic Disorders of the Pregnant Woman and Newborn Infant. Elsevier Science Publishing Co; New York: 1987
5 Henriksson P, Hedner U, Nilsson IM, Boehm J, Robertson B, Lorand L. Fibrin stabilizingfactor (factor XIII) in the fetus and the newborn infant. Pediatr Res 1974; 8: 789-791
6 Beverley DW, Inwood MJ, Chance GW, Schaus M, O’Keefe B. Normal haemostasis parameters: a study in a well-defined inborn population of preterm infants. Early Human Dev 1984; 9: 249-257
7 Barnard DR, Simmons MA, Hathaway WE. Coagulation studies in extremely premature infants. Pediatr Res 1979; 13: 1330-1335
8 Schettini E, De Mattia D, Altomare M, Montagna O, Ciavarella G, Manzionna MM. Post-natal development of protein C in full-term newborns. Acta Paediatr Scand 1985; 74: 226-229
9 Peters M, ten Cate JW, Jansen E, Breederveld C. Coagulation and fibrinolytic factors in the first week of life in healthy infants. J Pediatr 1985; 106: 292-295
10 Yamada K, Shirahata A, Meguro T. The comparative studies on factor XIII of newborn infants obtained by three methods; clot solubility, immunological and fluorescent assays. Acta Haematol Jpn 1976; 39: 79-84
11 Karpatkin M, Mannucci PM, Bhogal M, Vigano S, Nardi M. Low protein C in the neonatal period. Br J Haematol 1986; 62: 137-142
12 Polack B, Pouzol R, Amiral J, Kolodie L. Protein C level at birth. Thromb Haemostas 1984; 52: 188-191
13 Mibashan RS, Millar DS. Fetal haemophilia and allied bleeding disorders. Br Med Bull 1983; 39: 393-398
14 Holmberg L, Henriksson P, Ekelund H, Astedt B. Coagulation in the human fetus: comparison with term newborn infants. J Pediatr 1974; 85: 860-864
15 Ekelund H, Hedner U, Astedt B. Fibrinolysis in human foetuses. Acta Paediatr Scand 1970; 59: 369-376
16 Ekelund H, Hedner U, Nilsson IM. Fibrinolysis in newborns. Acta Paediatr Scand 1970; 59: 33-43
17 Terwiel J, Veltkamp JJ, Bertina RM, Muller HP. Coagulation factors in the human fetus of about 20 weeks of gestational age. Br J Haematol 1980; 45: 641-650
18 Andrew M, Massicotte-Nolan P, Mitchell L, Cassidy K. Dysfunctional antithrombin III in sick premature infants. Pediatr Res 1985; 19: 237-239
19 Schettini AU, De-Mattia E, Altomare D, Montagna M. Post-natal development of factor IX. Acta Paediatr Scand 1980; 69: 53-58
20 Johnson SS, Montgomery RR, Hathaway WE. Newborn factor VIII complex: elevated activities in term infants and alterations in electrophoretic mobility related to illness and activated coagulation. Br J Haematol 1981; 47: 597-606
21 Gordon EM, Ratnoff OD, Saito H, Gross S, Jones PK. Studies on some coagulation factors (Hageman factor, plasma prekallikrein, and high molecular weight kininogen) in the normal newborn. Am J Pediatr Hematol 1980; 02 (03) 213-216
22 Andrew M, Bhogal M, Karpatkin M. Factors XI and XII and prekallikrein in sick and healthy premature infants. N Engl J Med 1981; 305 (19) 1130-1133
23 Ekelund H, Finnstrom O. Fibrinolysis in pre-term infants and in infants small for gestational age. Acta Paediatr Scand 1972; 61: 185-196
24 Yamada K, Yamada Z. Active and potentially active forms of fibrin stabilizing factor (factor XIII) in various disorders and in neonatal infants. J Med 1968; 17 (02) 125-133
25 Sell EJ, Corrigan Jr JJ. Platelet counts, fibrinogen concentrations, and factor V and factor VIII levels in healthy infants according to gestational age. J Pediatr 1973; 82: 1028-1032
26 Corrigan Jr JJ, Sell EJ, Pagel C. Hageman factor and disseminated intravascular coagulation (DIC) in newborn and rabbits. Pediatr Res 1977; ll: 916-920
27 Manco-Johnson M, Marlar R, Jacobson L, Hays T, Warady BA. Severe protein C deficiency in newborn infants. J Pediatr 1988; 113: 359-363
28 Johnston M, Zipursky A. Microtechnology for the study of the blood coagulation system in newborn infants. In: Acquired Bleeding Disorders in Children Platelet Abnormalities and Laboratory Methods. Lusher JM, Barnhart MI. eds Masson, New York: 1981: 33-147
29 Terwiel J, Veltkamp JJ, Bertina RM, van der Linden I, van Tilburg NH. Coagulation factors in the premature infant born after about 32 weeks of gestation. Biol Neonate 1985; 47: 9-18
30 Schwarz HP, Munteen W, Watzke H, Richter B, Griffin JH. Low total protein S antigen but high protein S activity due to decreased C4b-binding protein in neonates. Blood 1988; 7l: 562-565
31 Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Powers P. Development of the human coagulation system in the fullterm infant. Blood 1987; 70: 765-772
32 Andrew M, Paes B, Milner R, Johnstoo M, Mitchell L, Tollefsen DM, Castel V, Powers P. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72: 165l-1657
33 Dube B, Dube RK, Bhargava K, Kolindewala JK, Kota VLN, Das BK. Hemostatic parameters in newborn. - I. Effect of gestation and rate of intrauterine growth. Thromb Haemostas 1986 55. 47-50
34 Ziptrsky A, deSa D, Hsu E, Johnston M, Milner R. Clinical and laboratory diagnosis of hemostatic disorders in newborn infants. Am J Pediatr Hematol Oncol 1979; 1: 217-226
35 Arbol P, Bhargavz V, Dube B, Tiwari AD, Sharma A. Hemostasis in healthy neonates. Indian Pediatr 1984; 2l: 671-675
36 Kolindewala JK, Dube B, Bhargava V, Dube RK, Kota VLN, Das BK. Hemostatic parameters in newborn, - II. Sequential study during the first four weeks of life. Thromb Haemostas 1986; 55: 51-53